{
    "nct_id": "NCT05056844",
    "official_title": "Contrast Enhanced Spectral Mammography (CESM) for the Evaluation of Pathologic Nipple Discharge: A Pilot Study",
    "inclusion_criteria": "* Women presenting to MDACC for the evaluation of PND as the main or accompanying symptom\n* Age 25-85 years\n* Willing to participate in the study and undergo an IV placement, able to undergo iodinated contrast injection, and able to provide informed consent\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 25 Years\nMust have maximum age of 85 Years",
    "exclusion_criteria": "* Reported history of an allergic reaction to iodinated contrast\n* History of anaphylactic reaction to any substance in the absence of a prior history of uneventful administration of iodine-based IV contrast.\n* Renal insufficiency\n* Pregnancy or lactation within 6 months\n* Breast surgery affecting the symptomatic breast within prior 6 months, if it was located within 5 cm from the nipple\n* Breast biopsy of the symptomatic breast within the last 2 months, if it was located within 5 cm from the nipple\n* Breast MRI performed within 24 months before the patient presented with qualifying symptoms (MRI performed contemporarily with CEM for the evaluation of new symptoms is not an exclusion criterion).\n* Known breast cancer or active inflammatory process (such as abscess or mastitis) in the breast of concern",
    "miscellaneous_criteria": ""
}